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Abstract
Background: Iron in the form of oral supplements is routinely prescribed to children to help fight anemia, however
tooth staining is a commonly reported complication. This study tests in vitro, the staining potential of two different
forms of iron syrup on primary teeth.
Methods: Forty caries free primary central incisors were divided into four groups of ten teeth each. The control
group comprised of ten teeth immersed in artificial saliva, while the test solutions were comprised of different
forms of iron mixed with vitamins such that the iron content of each solution was approximately 100 mg (from 100
to 101.1 mg). The test solutions used iron syrup (Ferrose®, SPIMACO, Jeddah, Saudi Arabia) with iron in the form of
ferric oxide polymaltose (FOP), slow release formula (Ferroglobin®, Vitabiotics ltd., London, UK) containing ferrous
fumarate (FF and a combination of the two (FOP + FF). All the teeth were then immersed for 72 h and subjected to
a protocol developed by Lee et al. to test staining. Color changes were measured using a wave dispersion
spectro-photometer (Color-Eye 7000A, X-Rite Gmbh, Regensdorf, Switzerland) on the exposed labial surface at 4, 8,
24, 48 and 72 h. Two-way ANOVA with Scheffe’s post hoc test was used to determine significance of difference in
shade, while the Kurskull-Wallis test used to determine the significance of difference in clinical staining (ΔE > 3).
Results: While all three iron groups showed some amount of staining, the combination of the two forms of iron
(FOP+FF) showed significantly lower incidence of clinical staining than the other two groups at the end of 72 h. At
the end of 72 h the (FOP) had significantly higher ΔE than ferrrous fumarate (FF ) while the combination (FOP+ FF)
had a significantly lower ΔE than either group.
Conclusion: In an in vitro model, combining different forms of iron seems to elicit a lower intensity of staining
than equivalent doses of a single form of iron.
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Background
Iron is found in all living tissues including enamel,
dentin and the dental pulp [1, 2]. Iron deficiency affects
more than two billion people in the world and is one of
the most common nutritional deficiencies [3]. Although
iron deficiency may sometimes result from defects in the
body’s ability to metabolize iron, the most common
cause is inadequate iron in the diet, a deficiency that is
treatable by foods and supplements which contain iron
salts [3, 4]. Iron salts in the form of supplements, usually
drops or syrups fortified with folic acid and/or vit. B12,
are often prescribed to children below 5 years of age [3].
While drops and syrups containing iron, folic acid and
Vit B12 have traditionally been the standard form of dis-
pensing iron salts, companies also incorporate these in-
gredients into infant formulas [4], and multi-vitamin
formulas [5].
The extrinsic staining of primary teeth is often a cause
of concern to parents and there have been reports that
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such staining can adversely affect the social interactions
of preschool children [6]. Since ferric sulfide is the
chemical insoluble form of iron supplement, it has been
suggested that it may interact (in ionic form) with gin-
gival cervical fluid and the bacterial hydrogen sulfide to
produce iron stains [7]. There is ample documentation
of iron staining reported on the teeth of children taking
iron syrups, drops and other preparations [5, 8–10].
While it has been shown that low dose iron in the
form of ferrous fumarate produces less tooth staining
than syrups [5], there is concern that these low dose for-
mulas do not provide adequate iron to prevent anemia
[11]. This has meant that physicians often prescribe high
dose iron syrups, with iron in the form of ferrous sulfate,
or more recently ferric hydroxide polymaltose complex
to help combat anemia [12]. There is little evidence to
highlight the staining potential of either the low dose
ferrous fumarate preparations or the newer ferric hy-
droxide polymaltose complex on primary teeth.
There are several methods to evaluate the change of
tooth color due to the deposition of stains, wavelength
dispersive spectro-photometry has been shown to be the
most accurate method for the assessment of dental
stains in general [13]. Furthermore the assessment of
color changes in the tooth in vitro has been shown to
yield reproducible results when done using a standard-
ized in vitro staining model [14].
The aim of the present study was to compare the
staining potential of iron supplements in the form of a
ferric hydroxide polymaltose and vitamin iron syrup, fer-
rous fumarate iron and vitamin formula and a combin-
ation of the two, using an in vitro staining model.
Methods
The current study used an in vitro experimental
model. Institutional ethical consent was obtained from
the ethics committee of the Riyadh Colleges of Dentistry
and Pharmacy and project was assigned the number
USRP/2013/76.
Teeth used
Forty caries free primary incisors extracted in patients
where parents’ desired extraction due to pre-shedding
mobility were used in the study. Teeth selected were free
from developmental defects, enamel hypoplasia, restora-
tions or existing extrinsic or intrinsic stains. The parents
were informed about the use of the teeth for research
purposes and written informed consent was obtained
from the parents. All teeth used in this study were ex-
tracted in a one month period from patients reporting to
the dental clinics of the college and sterilized by im-
mersing in 10 % formalin for 24 h by the clinical staff
before the teeth were made available for research pur-
poses. Once received, the teeth were thoroughly rinsed
and then stored in artificial saliva (Caphosol® Cytogen
Corp. Princeton NJ, USA ) from the time of extraction
until usage. The teeth were rinsed thoroughly and then
embedded in a circular acrylic resin mold 4 cm in diam-
eter such that the labial surface of these incisors was vis-
ible through a 2cm x 2cm window. The teeth were then
randomly divided into four groups of ten teeth each and
each group was immersed in one of the four prepared
solutions.
Preparation of solutions
Control Solution −250 ml of artificial saliva (Caphosol®
Cytogen Corp.).
Ferric Oxide Polymaltose Group (FOP) – 10 ml
(maximum therapeutic daily dose) containing of com-
mercially available iron, folic acid and vitamin B12
syrup (Ferrose®, SPIMACO, Jeddah, Saudi Arabia),
was diluted with artificial saliva (Caphosol® Cytogen
Corp.) to make up 250 ml such that the total avail-
able iron content in the solution was 100 mg in the
form of ferric hydroxide polymaltose complex.
Ferrous Fumarate Group (FF) – 35 ml of slow release
formula (Ferroglobin®, Vitabiotics ltd., London, UK) was
diluted with artificial saliva (Caphosol® Cytogen Corp.) to
make up 250 ml such that the total available iron content
in the solution was approximately 100 mg (100.2 mg) in
the form of ferrous fumarate.
Combination solution (FOP + FF ) – 10 ml of iron, folic
acid and vitamin B12 syrup (Ferrose®, SPIMACO, Jeddah,
Saudi Arabia) was combined with 15 ml of slow release
formula (Ferroglobin®, Vitabiotics ltd., London, UK ) to
produce 35 ml of a high concentration iron syrup (total
iron 142.94 mg). Twenty five milliliters of this was diluted
with artificial saliva (Caphosol® Cytogen Corp.) to make
up 250 ml such that the total available iron content in the
solution was approximately 100 mg (101.1mg).
Shade assessment
Baseline shades of all teeth were measured using a wave
dispersion spectro-photometer (Color-Eye 7000A, X-Rite
Gmbh, Regensdorf, Switzerland). The samples were re-
moved from the solution at 4, 8, 4, 48 and 72 h and rinsed
with distilled water. Shade was measured on the exposed
labial surface using the protocol developed by Lee et al.
[14] to obtain the CIE l*a*b values for change in color.
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A ΔE >3
(from the baseline score) was recorded as clinically
visible staining.
Statistical analyses
The baseline l* a* b values of the teeth assigned to each
group were compared using the One-Way ANOVA to
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test the effectiveness of randomization. The ΔE values
across groups were then subjected to statistical analysis
using the repeated measures two-way ANOVA and the
Scheffe’s post-hoc test to compare the intensity of stain-
ing between groups. The total number of teeth exhibit-
ing clinically visible staining was tabulated and was
tested for statistical significance using the Kurskull-
Wallis test and Mann–Whitney –U between different
groups as a post-hoc test. All analysis was done using
the SPSS ver. Twenty two data processing software. The
level of significance was set at p < 0.05. Since multiple
comparisons with the Mann–Whitney-U were per-
formed a Bonferroni correction was applied and the level
of significance was set at p < 0.01.
Results
There was no significant difference between the mean
baseline L*,a*,b* values of the teeth assigned to the dif-
ferent groups (Table 1).
When the repeated measures two-way ANOVA was
used to check the progression of staining among the dif-
ferent groups (Fig. 1) it was observed that the control
group showed no significant increase in ΔE across time
intervals. The test revealed significant differences across
time intervals (p < 0.001) for each of the iron containing
groups. Post-hoc tests showed that for the FF group there
was no significant difference at the 4, 8 and 24 h interval
(p = .102) however there was a significant increase in ΔE at
the subsequent 48 and 72h readings (p < 0.05). For the
FOP group there was no significant change in ΔE at the 4
and 8 h interval however there was a significant increase in
ΔE at the 24, 48 and 72 h intervals (p < 0.05). For the FF +
FOP group there was no significant difference in the 4, 8
and 24 h groups (p = .614), no significant difference between
the 24 and 48 h groups (p = .104) and a significant increase
at 72 h (p < 0.05). The findings are summarized in Fig. 1.
A comparison of mean ΔE values across the different
groups at 4 and 8 h showed that while the ΔE of the
control group was significantly lower than that of the
iron containing groups (p < 0.05), there was no signifi-
cant difference between the FF, FOP and FF + FOP
groups. At 24 h the control group had significantly lower
ΔE than the iron containing groups, however the ΔE of
the FF + FOP was significantly (p < 0.05) lower than that
of the FF and FOP groups. There was no significant
difference in the ΔE between the FF and FOP groups
(p = .252). By 48 h each of the groups had significantly
higher ΔE values than control group. The FOP group
showed significantly higher Δ E than all other groups.
These findings were also true at 72 h (Fig. 1). There ΔE
of the FF + FOP group was significantly lower than the
ΔE of the FF group at both 48 and 72 h.
The teeth were examined for clinically visible staining
(ΔE >3) only at the end of the72 h cycle. It was observed
that none of the teeth in the control group showed any
visible staining at the end of 72 h. All ten teeth in the
FOP group showed clinical staining, while eight out of ten
teeth in the FF group showed clinical signs of staining.
Only four out ten teeth in the FOP + FF group showed
clinical staining. It was seen that both the FF groups had
significantly greater number of stained teeth when com-
pared to the FF + FOP group, while there was no signifi-
cant difference in the number of stained teeth between
the FF and the FOP group or between the FF group and
the FF + FOP group(Table 2). Since none of the teeth of
the control group showed any clinical staining they were
not included in the tests of significance to eliminate un-
necessary comparisons or false significant statistics.
Discussion
The staining of teeth after administration of oral iron sup-
plements is not a universal phenomenon although some
studies have reported incidence of tooth staining in over
half the children receiving such supplements [3, 6, 15].
Since the aim of this study was to compare the staining
potential of different forms of iron rather than study the
actual staining potential of iron, we slected an in-vitro
model that was designed to induce staining rather [14]
than one of the newer staining models that are designed
to mimic cyclic exposure to stains [16]. To this end, we
had to follow a standardized protocol developed by Lee et
al. [14]; which has been used extensively to study the
staining potential of substances with a similar pattern of
exposure such as juices, coffees and colas [17, 18].
The ideal dose of additional iron has been a source of
debate with literature showing that while iron drops and
syrups contain between 12.5 to 50 mg of iron per dose
(5 ml), slow release iron formulae contain between 4 to
14.5 mg per dose [5, 12, 19]. While it has been shown
that low dose iron in the form of ferrous fumarate pro-
duces less tooth staining than syrups [5], there is con-
cern that these low dose formulas do not provide
adequate iron to prevent anemia [11]. It was for this rea-
son that this experiment sought to measure staining
potential of the supplements such that the iron content
of the staining solution would be roughly equal to the
prescribed therapeutic dose for a child with iron defi-
ciency anemia (100 mg/day) [3].
Table 1 Mean baseline L*, a*, b* values for teeth assigned to
each group
Value Mean (+/− SD) Sig*
Control FF FOP FF + FOP
L* 80.81 (+/− 1.7) 80.28(+/−2.1) 80.49(+/−2.3) 80.87(+/−2.5) .921
a* .278(+/−1.04) .374(+/−1.02) .178(+/−1.0) .243(+/−.96) .978
b* 15.82(+/−2.6) 16.14(+/−2.6) 17.64(+/−2.9) 16.88(+/−2.4) .421
* significance calculated using the One-Way ANOVA
Pani et al. BMC Oral Health  (2015) 15:90 Page 3 of 6
The combination of low dose ferrous fumarate with
high dose iron supplements has previously been shown to
reduce the side effects of iron [20]. Iron in the ferrous
form is more rapidly absorbed than in the ferric form and
combination regimens often prescribe higher doses of fer-
ric iron than ferrous iron [20–22]. It was for this reason
that we decided to combine the ferric oxide polymatose
with the ferrous fumarate in a ratio of 2:1. The results of
this experiment showed that in equivalent doses, the inten-
sity of stain produced by the solution containing ferrous
fumarate is significantly lower than the stain produced by
ferric hydroxide polymaltose; however the combination of
the two forms of iron produced significantly lower ΔE
values than equivalent doses of either.
The results show that while the FOP group started to
show significant change in ΔE after 24 h in the model, both
the FF and FF + FOP groups required 48 h before the ΔE
values started to increase significantly. This could be due to
the rapid nature chemical interaction of the ferric form of
iron as compared to the ferrous [5]. Nevertheless the fact
that significant changes in ΔE only began to emerge after
24 h of continuous exposure may explain why the staining
of teeth after the use of iron supplements is not a univer-
sally reported phenomenon [3, 5, 9, 12]. The intensity of
color change as recorded using the spectrophotometer are
reflected by ΔE values (Additional file 1), however it must
be remembered that ΔE values <2 are not perceptible to
the naked eye. For the purpose of this experiment it was
decided to designate a ΔE value of >3 as the presence of
clinical staining in keeping with the protocol followed in
previous studies [23, 24]. It is interesting to note that the
number of stained teeth at the end of 72 h was significantly
lower in the group that were immersed in a solution that
combined iron in the form of ferrous fumarate with iron in
the form of ferric hydroxide polymaltose. While previous
research has shown that combining different forms of iron
may reduce gastric irritation [21, 22], the results of this
study suggest that the hypothesis may also be true for stain-
ing of teeth. While our study did not measure the availabil-
ity of iron in each of the three solutions, previous research
has shown that combining different forms of iron does not
in any way reduce bio-availability [21, 22].
Fig. 1 The effect of time of immersion on the ΔE of the different groups of solutions. Difference in alphabet indicates significant difference
(p < 0.05) between groups at a given time interval while difference in symbol indicates difference between time interval for each group
(p < 0.05). Significance calculated using the Two Way Repeated Measures ANOVA and Scheffe’s Post-hoc test






FF 8ab 15.50 0.016
FOP 10b 20.00
FF + FOP 4a 11.00
a,bValues with different superscripts have a significant difference (p < 0.01)
when measured using the Mann–Whitney U test
cCalculated using the Kurskull Wallis Test
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The results of this study must be viewed keeping in
mind its limitations. No preservative was used to pre-
vent possible bacterial growth during storage although
mandatory sterilization by immersion in 10 % forma-
lin for 24 h was carried out by the clinical staff in
keeping with recommended guidelines [25]. The exact
mechanism by which iron causes tooth staining is still
not fully clear, with the hypothesis that iron binds to
the pellicle being the most accepted theory [6, 9].
The in vitro study model used in this study was one
that was designed to induce staining, and it was for
this reason that although the teeth were rinsed, they
were not polished to remove pellicle. It must be em-
phasized that in reality the incidence of clinical stain-
ing is far lower than that observed in this study.
However, it has been shown that exaggerated staining
protocols are useful in demonstrating the reduction in
staining potential and reduced or absence of staining
of teeth in such models can be indicative of low risk
of clinical staining [26]. The potential of iron to stain
teeth assumes greater significance in the light of re-
cent research into the effect of iron on dental erosion
and studies into the feasibility of incorporating iron
into mouth-rinses and aerated beverages [27]. The fact
that a majority of the teeth placed in the solution that
combined ferric and ferrous forms of iron is encouraging
and must be viewed keeping in mind sporadic pediatric
literature that have shown that combination of these two
forms of iron can reduce side effects [12, 20, 28]. While
the results of this study do not offer conclusive evidence
to frame a hypothesis the topic merits further research.
Conclusion
The results of this study indicate that iron has staining
potential on teeth when tested in vitro and ferrous oxide
polymaltose (FOP) presents worse results after longer
exposure periods (48 h). Both the occurrence of clinical
staining and the intensity of the staining are reduced
when the forms of iron are combined in an in vitro
model for 24h or more.
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